Sestamibi (AnazaoHealth Corporation)


Welcome to the PulseAid listing for the Sestamibi drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AnazaoHealth Corporation
NON-PROPRIETARY NAME: Sestamibi
SUBSTANCE NAME: TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-05-23
END MARKETING DATE: 0000-00-00


Sestamibi HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSestamibi from AnazaoHealth Corporation
LABELER NAME: AnazaoHealth Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 1.5(mg/1)
START MARKETING DATE: 2012-05-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51808-208_118e6927-25b5-4bcc-8716-fcb5dbdc487b
PRODUCT NDC: 51808-208
APPLICATION NUMBER:

Other TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationSestamibi
Lantheus Medical Imaging, Inc.Cardiolite
MALLINCKRODT NUCLEAR MEDICINE LLCTechnetium Tc 99m Sestamibi